Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2014First federal award
$11.7MFederal grants as PI11 awards
0Patents grantedNone matched
134Papers11,871 citations
Federal awards and patents by year
AwardsPatents
11 awards · $11.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 17, 2022 | NIH | SBIR Phase II A rationally-designed, live-attenuated RSV vaccine for the elderly | $809K | Codagenix Inc. |
| Jul 12, 2021 | NIH | SBIR Phase II A rationally-designed, live-attenuated RSV vaccine for the elderly | $665K | Codagenix Inc. |
| May 6, 2021 | NIH | SBIR Phase II Final Preclinical Testing and Formulation of a Scalable, Live-attenuated SARS-CoV-2 Vaccine | $999K | Codagenix Inc. |
| Jul 14, 2020 | NIH | SBIR Phase II Rapid generation and testing of live-attenuated vaccines against SARS-CoV-2 | $1.7M | Codagenix Inc. |
| Jul 2, 2020 | NIH | SBIR Phase II A rationally-designed, live-attenuated RSV vaccine for the elderly | $727K | Codagenix Inc. |
| Jul 2, 2020 | NIH | SBIR Phase II A rationally-designed, live-attenuated RSV vaccine for the elderly | $3.9M | Codagenix Inc. |
| Oct 12, 2018 | DoD | SBIR Phase II Development of a Flexible, Live Tetravalent Dengue Vaccine | $948K | Codagenix Inc. |
| Jul 6, 2018 | NIH | SBIR Phase II Pre-clinical Commercialization of a Synthetically Designed, Live-attenuated RSV Vaccine | $745K | Codagenix Inc. |
| Aug 15, 2017 | NIH | SBIR Phase II Pre-clinical Commercialization of a Synthetically Designed, Live-attenuated RSV Vaccine | $755K | Codagenix Inc. |
| May 5, 2015 | NIH | SBIR Phase I Ultra-low dose Influenza vaccines | $200K | Codagenix Inc. |
| Dec 9, 2014 | NIH | SBIR Phase I Balancing Immunogenicity of a Tetravalent Live Attenuated Dengue Vaccine | $223K | Codagenix Inc. |
1 patents as inventor
- US Codagenix Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#45
Awards as PI#106
Patents#273
Companies
- Codagenix Inc.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.